Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer

Expert Opinion on Investigational Drugs
Lars Henrik Jensen

Abstract

Patients with non-resectable biliary tract cancer have a poor prognosis even if treated with systemic chemotherapy. One hope for improving treatment is through molecular biology and the characterization of specific cancer driving alterations followed by the design of targeted drugs. The epidermal growth factor receptor system is upregulated in many cancers and can be targeted by the protein kinase inhibitor erlotinib. Erlotinib has demonstrated a clinically applicable effect in pancreatic and lung cancer Areas covered: In this review, the author presents the published clinical data about erlotinib in biliary tract cancer. The data is interpreted with respect to its clinical value and in regards to its future development. Erlotinib has low activity as a monotherapy, but has shown synergistic effects when combined with bevacizumab. The only phase III trial with erlotinib was negative, but suggested improved progression free survival in cholangiocarcinoma patients when added to gemcitabine and oxaliplatin. There is no clinical, radiological or molecular marker to guide therapy, but genomic profiling and basket or umbrella trials may be useful in identifying the subset of patients benefitting from erlotinib. Until this subgroup has...Continue Reading

References

Jan 1, 1992·Progress in Growth Factor Research·S A Prigent, N R Lemoine
Dec 22, 1999·American Journal of Preventive Medicine·D L Frosch, R M Kaplan
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip A PhilipCharles Erlichman
Dec 7, 2006·Cancer Chemotherapy and Pharmacology·Tomislav DragovichAmita Patnaik
Apr 25, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malcolm J MooreUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 20, 2007·Annals of Internal Medicine·Peder A HalvorsenIvar Sønbø Kristiansen
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·E Gabriela ChioreanChristopher J Sweeney
Apr 9, 2010·The New England Journal of Medicine·Juan ValleUNKNOWN ABC-02 Trial Investigators
Apr 15, 2010·Current Drug Targets·Marcus W Wiedmann, Joachim Mössner
Jun 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sam J LubnerKyle D Holen
Apr 21, 2011·Expert Review of Anticancer Therapy·Lars Henrik Jensen, Anders Jakobsen
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Feb 10, 2012·Journal of Hepato-biliary-pancreatic Sciences·Jason E Faris, Andrew X Zhu
Jul 20, 2012·Critical Reviews in Oncology/hematology·Donatella MarinoMassimo Aglietta
Mar 5, 2013·The Lancet Oncology· The Lancet Oncology
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Jun 8, 2013·Nature Medicine·Cassandra Willyard
Jul 5, 2013·The New England Journal of Medicine·Ethan Basch
Jan 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey R OxnardPasi A Jänne
Mar 4, 2014·Lancet·Nataliya Razumilava, Gregory J Gores
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lee M EllisLowell E Schnipper
Apr 29, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A LamarcaJ W Valle
Sep 2, 2014·European Respiratory Review : an Official Journal of the European Respiratory Society·Jessica MenisBenjamin Besse
Dec 31, 2014·World Journal of Gastroenterology : WJG·Heng LiuLun-Gen Lu
May 13, 2015·Best Practice & Research. Clinical Gastroenterology·N Schweitzer, A Vogel
Jul 21, 2015·Experimental and Molecular Pathology·Juan PutraArief A Suriawinata
Aug 13, 2015·Current Treatment Options in Oncology·Amartej MerlaLakshmi Rajdev
Oct 21, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BridgewaterJ W Valle

❮ Previous
Next ❯

Citations

Sep 3, 2016·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Mitsuhiro Fujishiro, Ichiro Yasuda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Related Papers

Therapeutics and Clinical Risk Management
Naureen StarlingDavid Cunningham
Gastrointestinal Cancer Research : GCR
Philip A Philip
Expert Opinion on Pharmacotherapy
Patricia A TangMalcolm J Moore
© 2022 Meta ULC. All rights reserved